StockNews.com Begins Coverage on Akari Therapeutics (NASDAQ:AKTX)
StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a report issued on Tuesday. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance NASDAQ:AKTX opened at $3.69 on Tuesday. Akari Therapeutics has a 12-month low of $2.81 and a 12-month high of $12.55. The stock’s […]
More Stories
Insider Selling: Total Energy Services Inc. (TSE:TOT) Senior Officer Sells 10,000 Shares of Stock
Total Energy Services Inc. (TSE:TOT – Get Free Report) Senior Officer Bradley John Macson sold 10,000 shares of the business’s...
Drucker Wealth 3.0 LLC Grows Position in Exxon Mobil Co. (NYSE:XOM)
Drucker Wealth 3.0 LLC grew its position in shares of Exxon Mobil Co. (NYSE:XOM – Free Report) by 1.6% during...
ProShares Ultra Silver (NYSEARCA:AGQ) Shares Gap Up – Should You Buy?
ProShares Ultra Silver (NYSEARCA:AGQ – Get Free Report)’s share price gapped up prior to trading on Monday . The stock...
Toast (NYSE:TOST) Given New $40.00 Price Target at Keefe, Bruyette & Woods
Toast (NYSE:TOST – Get Free Report) had its price target hoisted by research analysts at Keefe, Bruyette & Woods from...
Lufax (NYSE:LU) Shares Gap Up – Here’s What Happened
Lufax Holding Ltd (NYSE:LU – Get Free Report) gapped up prior to trading on Monday . The stock had previously...
Sendas Distribuidora (NYSE:ASAI) Hits New 52-Week Low – Here’s Why
Sendas Distribuidora S.A. (NYSE:ASAI – Get Free Report) shares reached a new 52-week low during mid-day trading on Monday ....